CMV seroprevalence refers to the proportion of a population that has been infected with cytomegalovirus, as indicated by the presence of antibodies in their blood. Understanding CMV seroprevalence helps in assessing public health risks and guiding vaccination and prevention strategies, particularly for vulnerable groups like pregnant women and immunocompromised individuals.